GLORIA

GEOMAR Library Ocean Research Information Access

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Online Resource
    Online Resource
    Berlin, Heidelberg :Springer Berlin / Heidelberg,
    Keywords: Electronic books.
    Type of Medium: Online Resource
    Pages: 1 online resource (272 pages)
    Edition: 1st ed.
    ISBN: 9783642816642
    Series Statement: Medizinische Informatik, Biometrie und Epidemiologie Series ; v.29
    Language: German
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1534-4681
    Keywords: Soft tissue sarcoma ; Liposarcoma ; Epidemiology ; Treatment ; Survival
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Background: In general, although biological behavior and prognosis of liposarcomas (LPS) are more favorable compared with most other soft tissue sarcomas (STS), prognosis can vary widely depending on tumor characteristics, especially histological subtype and tumor grade. Patients and Methods: All consecutive, completely resected stage I-III LPS (as determined by the American Joint Committee on Cancer staging guidelines), treated at the Groningen University Hospital from 1977–2000, were analyzed. Results: A total of 69 patients, 35 males and 34 females, median age 51 (range 11–80) years, were reviewed. After a median follow-up of 71 (range 5–231) months, the overall local recurrence and metastasis rate at five years after diagnosis were 27% and 16%, respectively. Retroperitoneal localization was a significant negative prognostic factor regarding local recurrence; dedifferentiation, grade II-III, and deep location regarding distant metastasis; and dedifferentiation, grade II-III, stage II-III, size .20 cm and non-radical resection regarding survival. Conclusions: LPS have a relatively mild biologic behavior, with the exception of very large, deeply located, dedifferentiated and/or grade II-III LPS. Radical resection is important for diseasespecific survival. LPS have a relatively mild biologic behavior, with the exception of very large, deeply located, dedifferentiated and/or grade II-III LPS.
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    Electronic Resource
    Electronic Resource
    Springer
    Journal of neurology 202 (1972), S. 307-322 
    ISSN: 1432-1459
    Keywords: Fabry's Disease ; Angiokeratoma Corporis Diffusum ; Glycolipid Metabolism ; Disorder ; Trihexosyl-ceramide ; Teleangiectases
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Zusammenfassung Bei dem X-chromosomal vererbten Angiokeratoma corporis diffusum universale (Fabry) findet sich eine Ablagerung der Glykolipide Trihexosylceramid (Galaktosyl-galaktosyl-glucosyl-ceramid) und Dihexosylceramid (Galaktosyl-galaktosyl-ceramid) hauptsächlich in folgenden Zellen und Körpergeweben: autonome Ganglienzellen des Zwischenhirns und Hirnstamms; Hypophyse; Plexus myentericus und submucosus von Magen und Darm; Herzmuskulatur; glatte Muskulatur der Gefäße; viscerale Organe (Nierentubuli und -glomeruli). Neurologische Störungen entstehen weniger durch die primäre Glykolipidspeicherung im Zentralnervensystem (Akromegalie, Störungen der Temperaturregulation), als vielmehr infolge cerebrovasculärer Veränderungen (sensible und motorische Halbseitenerscheinungen. Hirnnervenstörungen, Psychosyndrome). Die fast stets vorhandenen Akroparaesthesien und Extremitätenschmerzen sind wahrscheinlich ebenfalls gefäßbedingt. Bei einem 21jährigen Mann konnten wir klinisch und elektromyographisch neuromuskuläre Störungen feststellen. Während als Ursache für das Myopathie-Syndrom eine Glykolipidanreicherung in der Skeletmuskulatur in Frage kommt, ist die Neuropathie vermutlich eher vasculärer Natur. Neuropathologische Veränderungen und neurologische Symptome bei Fabryscher Krankheit werden zusammenfassend dargestellt.
    Notes: Summary In the X-linked angiokeratoma corporis diffusum universale (Fabry) the glycolipids trihexosyl-ceramide (galactosyl-galactosyl-glucosyl-ceramide) and dihexosyl-ceramide (galactosyl-galactosyl-ceramide) are deposited mainly in the following cells and tissues: the autonomous neurons of the diencephalon and brain stem; the pituitary gland; the mesenteric and submucosal plexus of the gastrointestinal tract; the heart muscle; the vascular smooth muscles; the visceral organs (renal tubules and glomeruli). Neurological symptoms are due to cerebrovascular changes (sensory and motor unilateral lesions, cranial nerve defects and psychosyndromes) rather than to primary deposits of glycolipids in the central nervous system (acromegaly, impaired temperature regulation). Acroparesthesias and pain in the extremities found in almost every case are probably also caused by vascular disturbances. In a 21-year-old male neuromuscular alterations were found clinically and on electromyography. It is suggested that the myopathy is due to a deposition of glycolipids in the skeletal muscles, whereas the neuropathy is due to vascular disturbances. Neuropathological alterations and neurological symptoms in Fabry's disease are reviewed.
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    Electronic Resource
    Electronic Resource
    Springer
    Naunyn-Schmiedeberg's archives of pharmacology 249 (1964), S. 295-305 
    ISSN: 1432-1912
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Summary The species tolerance to toxic or lethal doses of atropine is generally ascribed to different rates of elimination. The rabbit particularly is thought to be protected by a specific serum esterase. The rate of elimination of atropine in rabbits by continuous intravenous infusion at different dosages (mg/kg · hr.) was determined and compared with our earlier experiments on cats. The blood pressure and pulse rates were recorded during periods of constant electric stimulation of the efferent vagus trunk. The maintenence infusion dose was determined after a single parasympathicolytic dose, and the values for the elimination per hour were found to be as follows: cats 0.07–0.09 mg/kg=230% of the effective single dose rabbits 0.06–0.07 mg/kg=130% of the effective single dose. In insensitive rabbits, where the presence of a specific esterase in the serum could demonstrated, we found the necessary single dose of atropine and the rate of elimination to be considerably higher. The elimination per hour amounted to 3,2–6,4 mg/kg, which likewise corresponded to 200–400% of the effective single dose. These results were compared with the toxicity and the therapeutic effects of atropine in man. The therapeutic potency in man is greater, but the rate of elimination considerably lower. The well-known high toxicity of atropine in man cannot be compared with the conditions in the more resistent species of animals, since the cause of death is not the same.
    Notes: Zusammenfassung Unterschiede verschiedener Tierarten in der Atropinresistenz gegen toxische oder letale Dosen werden meist auf Unterschiede in der Eliminationsgeschwindigkeit zurückgeführt. Insbesondere das Kaninchen soll durch eine spezifische Serumesterase geschützt sein. Es wurde im Vergleich zu früheren eigenen Untersuchungen an Katzen die Eliminationsgeschwindigkeit für Atropin bei Dauerinfusion verschiedener Dosen (mg/kg · Std) an Kaninchen ermittelt. Die Tiere hatten vorher eine parasympathicolytische Einzeldosis erhalten. Die Dosierungsgeschwindigkeit, bei der die Vaguslähmung aufrechterhalten werden konnte, wurde bei konstanten elektrischen Reizbedingungen am efferenten Vagusstamm unter Registrierung von Blutdruck und Pulsfrequenz bestimmt. Es wurde dabei als Eliminationsgröße pro Stunde gefunden: für Katzen 0,07–0,09 mg/kg=230% der wirksamen Einzeldosis für Kaninchen 0,06–0,07 mg/kg=130% der wirksamen Einzeldosis. An unterempfindlichen Kaninchen, bei denen im Serum das Vorkommen einer spezifischen Esterase nachweisbar war, fanden wir die erforderliche Atropin-Einzeldosis und die Eliminationsgröße wesentlich erhöht. Die Elimination pro Stunde betrug 3,2–6,4 mg/kg. Dies entsprach aber auch nur 200–400% der wirksamen Einzeldosis. Diese Befunde wurden mit dem Verhalten beim Menschen hinsichtlich Toxicität und therapeutischer Wirksamkeit von Atropin verglichen. Die therapeutische Wirksamkeit am Menschen ist größer, aber die Eliminationsgeschwindigkeit wesentlich geringer. Die bekannte hohe Toxicität von Atropin am Menschen kann nicht mit den Bedingungen bei den resistenteren verschiedenen Tieren verglichen werden, weil die Todesursache nicht die gleiche ist.
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    Electronic Resource
    Electronic Resource
    Springer
    Naunyn-Schmiedeberg's archives of pharmacology 249 (1964), S. 306-324 
    ISSN: 1432-1912
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Summary The remarkable tolerance of large doses of atropine in cases of alkyl phosphate poisoning, as well as the favorable action of cholinergic agents in the treatment of atropine poisoning induced us to reinvestigate experimentally the effectiveness of some cholinergic drugs as antidots against toxic doses of atropine. Under constant electric stimulation of the vagus trunk in the rabbit the neostigmine-atropine antagonism was examined with alternately increasing dosages. An “increasing antagonism” was found up to the 10-fold minimal effective dose of atropine. Dosages exceeding the 10-fold minimal effective dose gave rise to a “decreasing antagonism”. Higher concentrations of neostigmine often could not be tested because of their depressant action on respiration. In atropine-resistant rabbits, where 50 × the usual dose of atropine was necessary to abolish the response to vagus stimulation, a single dose of neostigmine sufficed to antagonize the inhibition in this range. In isolated rat auricles the limiting concentrations were determined for the antagonism of Doryl (carbaminoylcholine), eserine, neostigmine and pilocarpine respectively against atropine. After administration of increasing atropine concentrations only Doryl in extremely high doses was able to remove the atropine effect; cholinesterase inhibitors and pilocarpine were ineffective. Therefore the latter substances should not be expected to exert an antidotal effect on the heart in cases of atropine poisoning. The so-called “central cholinolytic” activity of atropine against increasing doses of eserine and arecoline was examined in mice. Atropine, even in the largest doses, showed only slight inhibitory influences on the eserine convulsions. The arecoline convulsions on the contrary were inhibited with distinct dependence on the atropine dosage (1–10 mg/kg). This antagonism seems to be “parallelly proportionate” (parallelgleitend). Eumydrin (N-methyl-atropine-nitrate) as a quaternary ammonium derivate cannot penetrate into the CNS in sufficient amounts to counteract the arecoline effects. The antagonism of atropine and cholinergic drugs on the activity of the autonomic efferent vagus and the phrenic nerve (motor nerve) was examined in urethane numal-anesthetized rats. Again the results were compared with Eumydrin which is only peripherally active. Eserine exerted a depression of impulses in both nerves; they were restored by atropine. With increasing doses of this combination the atropine dominated so that the eserine dose must be increased more than the atropine dose. Neostigmine itself had no effect on the activity of the respiratory and vagus centers. Pilocarpine was tested under protection of Eumydrin. It induced no bradycardia or central vagus stimulation. It also showed no antidotal effect as an atropine antagonist. Arecoline under Eumydrin protection produced a nicotine-like central excitation, which could be abolished by atropine in relatively large doses (more than 1 mg/kg). With an increase of atropine dose the antagonist effect of arecoline was diminished. 30–60 mg/kg were necessary to antagonize 10 mg/kg of atropine. It was interesting to observe an effect of arecoline on raising and of atropine on lowering the blood pressure. The results don't support the possibility of a rational treatment of atropine poisoning with the different types of cholinergic drugs.
    Notes: Zusammenfassung Die gute Verträglichkeit von sehr hohen Atropindosen bei Vergiftungen mit Alkylphosphaten und die Beobachtung über günstige Wirkungen von Parasympathicomimetica bei der Behandlung von Atropinvergiftungen gaben Veranlassung, die Möglichkeit einer Antidotwirksamkeit solcher Parasympathicomimetica gegenüber Atropin in toxischen Dosen experimentell zu prüfen. Bei konstanter Vagusreizung am Kaninchen wurde der Neostigminantagonismus zu Atropin bei welchselweiser Dosensteigerung geprüft. Es zeigte sich dabei ein „mitsteigender Antagonismus“, wenn die Atropindosis nicht über die zehnfache Grenzdosis erhöht wurde. Ein „zurückbleibender Antagonismus“ war erkennbar, wenn Atropindosen über die zehnfache Grenzdosis gewählt wurden. Höhere Neostigmingaben waren oft nicht mehr möglich, weil sie schon selbst die Atmung lähmten. An atropinresistenten Kaninchen, deren Vagus erst mit 50fach höheren Dosen ausgeschaltet werden konnte, genügte für den Antagonismus in diesem Grenzbereich eine übliche Neostigmindosis. Am isolierten Herzvorhofpräparat der Ratte wurden die Grenzkonzentrationen für den Antagonismus zwischen Doryl (Carbaminoylcholin), Eserin, Neostigmin und Pilocarpin einerseits, Atropin andererseits ermittelt. Bei Vorbehandlung mit steigenden Atropinkonzentrationen vermochte nur Doryl in vielfach stärkeren Dosensteigerungen wieder Vaguseffekte auszulösen, nicht dagegen die Esteraseblocker und Pilocarpin. Man darf also bei toxischen Atropindosierungen keine Antidoteffekte mit den letztgenannten Stoffen am Herzen erwarten. An Mäusen wurde die sogenannte „zentral -cholinolytische“ Wirksamkeit von Atropin gegenüber steigenden Dosen von Eserin und Arecolin geprüft. Atropin vermochte den Eserinkrämpfen gegenüber nur eine geringe Hemmwirkung auch in höchsten Dosierungen auszuüben. Der Arecolinkrampf ließ sich dagegen in deutlicher Abhängigkeit von der Atropindosierung (1–10 mg/kg) verhindern. Dieser Antagonismus scheint „parallel gleitend“ zu sein. Eumydrin (N-methyl-Atropin-Nitrat) als quaternisiertes Alkaloid kann nicht genügend ins ZNS eindringen, um die Arecolinwirksamkeit aufzuheben. An Urethan-Numal-betäubten Ratten wurde der Antagonismus von Atropin und Parasympathicomimetica auf die Aktivität des vegetativefferenten Vagus und des motorischen N. phrenicus studiert. Dabei wurde wieder Eumydrin, welches nur peripher vaguswirksam ist, zum Vergleich herangezogen. Eserin bewirkte eine Depression der Impulse in beiden Nerven; sie ließ sich mit Atropin aufheben. Bei Dosensteigerung der beiden Partner überwog der Atropineffekt, so daß die Eseringaben in höherem Ausmaß gesteigert werden mußten. Neostigmin hatte keine Eigenwirkung auf die Erregungsvorgänge im Atmungs- und Vaguszentrum. Pilocarpin wurde unter Eumydrinschutz geprüft. Es löste keine Bradykardie und zentrale Vaguserregung aus. Auch im Antagonismus zu Atropin zeigte es keine zentralen Antidotwirkungen. Arecolin lieferte unter Eumydrinschutz nicotinartige zentrale Erregungswirkungen, die von Atropin in höheren Dosen (ab 1 mg/kg) aufgehoben werden konnten. Bei Atropindosensteigerungen blieb im Antagonismus die Arecolinwirksamkeit zurück. Erst Arecolin 30–60 mg/kg wirkten gegenüber Atropin 10 mg/kg. Dabei zeigte sich eine blutdrucksteigernde Wirksamkeit von Arecolin gegenüber der Blutdrucksenkung nach Atropin. Die beschriebenen Ergebnisse beweisen nicht die Möglichkeit einer rationellen Behandlung der Atropinvergiftung mit den verschiedenen Parasympathicomimetica.
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    ISSN: 1432-1459
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Zusammenfassung Bei einem 37jährigen Patienten mit familiärer Belastung und einem 43jährigen Patienten ohne bekannte familiäre Belastung konnte das Vorliegen einer metachromatischen Leukodystrophie klinisch ohne Hirnbiopsie gesichert werden. Es bestanden folgende progrediente Krankheitssymptome: neurasthenische Erscheinungen, langsam zunehmender Persönlichkeitsabbau, passagere psychotische Symptome, (zunächst nur) mäßig ausgeprägte neurologische Störungen (Reflexdifferenzen, leichte Tonussteigerungen und Paresen, Pyramidenbahnzeichen, cerebelläre, leichte extrapyramidale und Sprachstörungen), zunehmender dementiver Abbau. Die Gallenblasenfunktion war (im Gegensatz zur kindlichen Krankheitsform) nur in einem Fall gestört. Die motorische Nervenleitgeschwindigkeit war deutlich herabgesetzt. Die lumbale Liquoreiweißmenge bewegte sich zwischen 45 und 60 mg-%. Im Urin waren histochemisch (Kresylviolett, Trypaflavin) metachromatische Substanzen nachweisbar. Dünnschichtchromatographisch fand sich eine deutlich vermehrte Sulfatidausscheidung im Urin, außerdem lag ein Arylsulfatase A-Defekt vor. Die Diagnose konnte weiterhin durch den Nachweis metachromatischer Substanzen bei Markscheidenzerfall im peripheren Nerven nach Suralisbiopsie erhärtet werden.
    Notes: Summary Most cases of metachromatic leukodystrophy (ML) occur in early childhood. Adult cases are rarely observed and the diagnosis in most patients was established by post-mortem examination. This communication describes the diagnosis confirmed in 2 living patients. Case 1 was a 37-year-old male whose sister had suffered from ML. Case 2 was a 43-year-old male and had no apparent hereditary taint in his medical history, although there is some indication that one of his sisters may be developing the disease. The diagnosis of our 2 patients was based upon increased urinary excretion of sulfatides, storage of metachromatic substances (stained with acriflavine) in epithelial cells of the urinary sediment and deposits of sulfatides within the peripheral nerves (biopsy of n. suralis). In addition, there was a marked decline of arylsulfatase A activity in the urine. The clinical picture was unspecific in both cases. Psychiatric examination revealed neurasthenic and temporary psychotic symptoms. Neurological observation showed differences of reflexes, slight muscular rigidity and spasticity, slight pareses of the limbs, tremor, and cerebellar disturbances. Both patients exhibited a hasty, scanning and explosive speech, which seems to be characteristic of the disease. As the disease slowly progressed, these symptoms increased and some mental deterioration occurred. The EEG showed a slowing of activity, dysrhythmic and sometimes focal and paroxysmal abnormalities. Later on, typical spikes were recorded. In the pneumoencephalogram a considerable hydrocephalus internus and externus was found in both cases. The cerebrospinal fluid showed a normal or slightly raised (45–60 mg%) protein content. As described in infantile cases, evidence of decreased conduction velocity, which indicates peripheral neuropathy, is of great importance. In our cases, conduction velocity was 38–39 m/sec in the ulnar nerve and of 19–34 m/sec in the peroneal nerve. This corresponds to the marked metachromatic breakdown of myelin sheaths which was observed in the n. suralis biopsy of both cases. The function of the gall bladder was normal in case 1, but disturbed in case 2. To date 21 genuine cases of adult ML developing after the second decade of life have been described in the literature. These include both the present cases and the sister of patient 2, who already shows some early abnormalities due to the disease. Our observations suggest that ML in the adult may not be as rare as is at present supposed.
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    Electronic Resource
    Electronic Resource
    Springer
    Journal of neurology 195 (1969), S. 283-300 
    ISSN: 1432-1459
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Zusammenfassung Nach Mitteilung vier eigener Beobachtungen von Kranken mit Arteria primitiva trigemina (A.pr.tr.) und neurologischen Ausfallserscheinungen wird auf der Basis strömungsmechanischer Befunde und an Hand der klinischen Ausfallserscheinungen die mögliche Pathogenese derselben erörtert. Die volumenstarke persistierende A.pr.tr. wirkt als Shunt-Gefäß zwischen den Durchströmungsgebieten der A. carotis int. und der A. basilaris und begünstigt auf dieser Basis eine relative Carotis- bzw. Mediainsuffizienz. Die klinisch-neurologische Symptomatologie ist dementsprechend grundsätzlich durch eine armbetonte Hemiparese (u. U. kombiniert mit Aphasie) gekennzeichnet, wobei die Intensität der Störungen den ausbildungsfähigen (vornehmlich meningealen) Kollateralkreislaufmöglichkeiten entspricht. Entsprechend der relativen Carotis- bzw. Mediainsuffizienz ist die klinische Symptomatologie bevorzugt durch alle den Gesamtkreislauf instabilisierenden Faktoren zu provozieren. Krankheitsfälle mit persistierender A.pr.tr. weisen relativ häufig gleichzeitig (komplette oder partielle) Verschlüsse der homolateralen A. cerebri media auf. Eine pathogenetisch möglicherweise maßgebliche Bedingung hierfür über lokale Strömungsverlangsamungen im cranialen Abschnitt des Carotissyphon wird diskutiert. Die ebenfalls relative Häufigkeit einer Kombination von persistierender A.pr.tr. mit Subarachnoidalblutungen kann nach den klinischen Befunden pathogenetisch nicht erklärt, sondern nur beschrieben werden.
    Notes: Summary Following the report of four own cases with an A. primitiva trigemina (A.pr.tr.) and the description of neurological symptoms the possible pathogenesis is discussed on the basis of rheological findings and clinical symptoms. The voluminous A.pr.tr. acts as a shunt between the area supplied by the internal carotid artery and the basilar artery, respectively, thus promoting a relative insufficiency of the carotid or median artery. Accordingly, the clinical-neurological symptoms are consistently marked by a hemiparesis, especially of the arm (sometimes associated with aphasia), the intensity of the disturbances depending on the extent to which a collateral (meningeal, especially) may become effective. Due to the relative insufficiency of the carotid and median artery, respectively, clinical symptoms will become apparent during any kind of circulatory distress. Cases with persistent A.pr.tr. relatively often present concurrent (complete or partial) occlusions of the homolateral A.cerebri media. In discussing pathogenetic possibilities regional decreases of blood flow within the cranial portion of the carotid syphon are considered to play an important role. The also relatively frequent coincidence of the persistent A.pr.tr. with a subarachnoid hemorrhage fails to lend itself to a pathogenetic explanation on clinical grounds and therefore can only be described.
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    ISSN: 1573-742X
    Keywords: endotoxin ; plasminogen activator inhibitor-1 ; tissue-type plasminogen activator ; smooth muscle ; rat ; rabbit
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Background Lipopolysaccharide (endotoxin) has been shown to increase the expression of plasminogen activator inhibitor type-1 (PAI-1) in the vessel wall. Endotoxin is known to increase PAI-1 production in endothelial cells, but its action on smooth muscle cells (SMCs) is presently not clear. In this study we determined the effect of endotoxin on PAI-1 and tissue plasminogen activator (t-PA) production by aortic SMCs in vivo in two animal species, and in culture. Methods The aortas of Sprague Dawley rats and of New Zealand White rabbits were rapidly excised after parenteral administration of endotoxin. Total RNA was extracted from the aortic media, and PAI-1 and t-PA mRNA levels were quantified after Northern blotting. In addition, cultured rat aortic SMCs were treated with endotoxin. PAI activity in the conditioned medium was determined with a spectrophotometric assay, and total RNA was extracted from the cells and analyzed. Results A rapid and strong induction in the aortic media of PAI-1 mRNA was observed by endotoxin in both rat (50 mg/kg) and rabbit (1 mg/kg). t-PA mRNA was barely detectable and was not increased by endotoxin. Studies in cultured SMCs showed low expression of PAI-1 mRNA under serum-free conditions and little PAI activity in the cell-conditioned medium. Endotoxin did not increase the levels of PAI-1 mRNA nor PAI activity under serum-free conditions. The effect of endotoxin (10 mg/ml) in the presence of 10% (v/v) newborn calf serum on PAI-1 mRNA was negligible; PAI activity, however, increased by 50.3 ± 7.3% compared with controls. mRNA levels of t-PA and low-density lipoprotein/receptor-related protein/α2-macroglobulin receptor also increased after endotoxin administration. PAI activity was identified as PAI-1 by immunoblotting. Fibrin zymography showed that t-PA was present only in complex with PAI-1. Conclusions A strong increase in PAI-1 gene expression by endotoxin was observed in aortic SMCs in vivo but not in culture. This suggests that the effect of endotoxin on SMCs is indirect. The fibrinolytic/proteolytic potential of the SMCs in the vessel wall is likely to have important implications for the migration of cells during vessel wall remodeling, such as neointima formation, during tumor cell metastasis, and for the fate of intramural thrombi.
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    Electronic Resource
    Electronic Resource
    Hoboken, NJ [u.a.] : Wiley-Blackwell
    Journal of Orthopaedic Research 4 (1986), S. 86-89 
    ISSN: 0736-0266
    Keywords: Bone cement ; Total joint replacement ; Mechanical testing ; In vivo model ; Life and Medical Sciences
    Source: Wiley InterScience Backfile Collection 1832-2000
    Topics: Medicine
    Notes: Flexural strength and molecular weight of polymethylmethacrylate bone cement were determined for cement polymerized in vivo in a canine total hip replacement and cement from the same batch polymerized in vitro. Both in vivo and in vitro samples showed a slight increase in flexural strength and modulus at 2 weeks, followed by a nearly equivalent decline at 8 weeks. In vitro and in vivo samples exhibit a comparable stress to failure, but the in vivo samples show a significantly increased strain and decreased modulus. Cement from the proximal region of the prosthesis has significantly decreased flexural strength, lower modulus, and lower molecular weight than cement from the distal region and plug, suggesting that failures in the proximal region of a prosthesis may be due to inferior physical and mechanical properties of the bone cement in that region.
    Additional Material: 2 Ill.
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 10
    Publication Date: 2016-04-15
    Description: During the Messinian, 6 m.y. ago, massive sea-level fall and widespread deposition of evaporites occurred in the Mediterranean Sea when it became isolated from the world oceans. Here we present the first hydrogen isotope data from individual sedimentary biomarkers, n-alkanes and isoprenoids, that tracked climatically driven hydrographic changes in response to extreme evaporation during the Messinian salinity crisis. The stable hydrogen and carbon isotope compositions of these biomarkers show a range of 160‰ in δD values and 14‰ in δ13C values, and roughly covary. This indicates that the source waters of the biomarkers were therefore in some cases extremely enriched in deuterium, having average δD as great as +66‰ VSMOW (Vienna standard mean ocean water). Such values are only known from desert climates today. Because the offset between the δD values of n-alkanes and isoprenoids preserved in the Miocene sedimentary rocks is similar to the offset found in modern biological samples, we conclude that diagenesis did not significantly affect the primary deuterium concentrations.
    Type: Article , PeerReviewed
    Format: text
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...